Initial results of BMS-986012, a first-in-class fucosyl-GM1 mAb, in combination with nivolumab, in pts with relapsed/refractory (rel/ref) small-cell lung cancer (SCLC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chu, QS-C
  • van Herpen, C
  • Leighl, NB
  • Markman, B
  • Clarke, S
  • Juergens, Rosalyn
  • Basciano, P
  • Lathers, D
  • Tannenbaum-Dvir, S
  • Urbanska, K
  • Kollia, G
  • Darby, C
  • Williams, D
  • Kolaitis, G
  • Ready, N

publication date

  • September 1, 2017